Pharmafile Logo

global access

Sanofi reception

Sanofi has 65 new compounds in development, says R&D chief

Elias Zerhouni to showcase pharma company's pipeline, promises costs will be rigorously managed

- PMLiVE

Biotech challenging big pharma for M&A deals

Purchasing power growth of 'big biotech' outpaces pharma sector

- PMLiVE

Novo Nordisk appoints new US legal affairs head

Promotes Curtis Oltmans from deputy counsel, legal and quality affairs

- PMLiVE

WPP forges ahead on its acquisition trail

Group takes stakes in Latin American innovative software company Globant and Sydney-based experiential marketing agency, PLAY Communication

Daiichi Sankyo launches Alzheimer’s campaign

Disease awareness drive will include TV commercials, newspaper adverts and a website

- PMLiVE

Sexual health apps fail to attract smartphone users

HIV and STD apps not fulfilling their potential to assist with prevention and care

Roche - Basel

Roche ends pursuit of gene sequencing company Illumina

Says chairman Franz Humer following failed $6.8bn bid

- PMLiVE

Lilly delivers upbeat earnings forecast for 2013

New products will offset generic competition for Alimta, Zyprexa, Cymbalta and Evista

- PMLiVE

Sanofi enters vaccines partnership with Sutro

Will develop products for two undisclosed targets

- PMLiVE

Biogen submits haemophilia drug for US approval

Step forward for its partnership with Swedish Orphan Biovitrum

Building brand strength – Part 2

The Iconic Brands series to help you create your brand's unique DNA

- PMLiVE

Agneta Svedberg appointed COO at Zealand Pharma

Succeeds company co-founder John Hottel who retires

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links